Clindamycin phosphate 1% foam 50GM
Ended Awarded
- Contract number
- SPE2DB25FSCQJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,426
Award facts
- Contract value 100% obligated
- $2,425.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,425.95 to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Foam in 50-gram units. This contract, awarded on August 11, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open competition. As a child contract, this delivery order derives from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that supplies a comprehensive range of medications and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's federal work encompasses diverse pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's demonstrated capability to fulfill federal medical supply requirements through competitively awarded contracts—ranging from small transactions to substantial orders—positions it as a key supplier for military and veteran healthcare systems. The DLA Troop Support is currently planning next-generation Pharmaceutical Prime Vendor Global Program contracts with anticipated multiple awards across separate regions, which may involve additional contractors.
Quick answers
Who was awarded contract SPE2DB25FSCQJ?
SPE2DB25FSCQJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FSCQJ worth?
The government has obligated $2,426 on SPE2DB25FSCQJ.
Is contract SPE2DB25FSCQJ an order under another contract?
Yes. SPE2DB25FSCQJ is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSCQJ competed?
The extent of competition for SPE2DB25FSCQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award